Twist Bioscience Corporation (TWST) amerykańska spółka wysoko w górę bo prowadzi badania leku na raka polskiego Pure i zasięg wzrostów 10000%:
"On this front, there is potential for Twist to begin making progress in coming years. Pure Biologics is advancing an antibody candidate developed by Twist into an exploratory phase 0 study. The study aims to assess the pharmacodynamic activity of PBA-0405 in solid tumors. PBA-0405 is a fully human IgG1 antibody that was discovered using Twist Biopharma Solutions’ synthetic antibody phage display libraries. Twist also recently published preclinical data for its TB206-001 antibody. This antibody has demonstrated in vivo tumor suppressing activity and is available for licensing."